Sensitivity testing for Helicobacter pylori should be more widely available

BMJ 1996; 313 doi: 10.1136/bmj.313.7064.1079c (Published 26 October 1996)
Cite this as: BMJ 1996;313:1079.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. G Cammarota, Investigator in gastroenterology,
  2. A Tursi, Investigator in gastroenterology,
  3. A Papa, Investigator in gastroenterology,
  4. G Fedeli, Professor of gastroenterology,
  5. G Gasbarrini, Director of internal medicine and gastroenterology schools
  1. Departments of Internal Medicine and Gastroenterology, Catholic University of Rome, 00168 Rome, Italy

    EDITOR,—Greg Rubin and Richard Stevens are right to ask for the wider availability of non-invasive diagnostic tests for managing Helicobacter pylori infection in primary care.1 We believe that the implementation of management guidelines for peptic ulcer disease also requires the wider availability of tests to determine the sensitivity of H pylori, because increased prescribing of antimicrobial drugs to treat the infection may be associated with increased drug resistance. Furthermore, our data indicate that if the global eradication …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL